Netcall (LON:NET) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

Netcall plc (LON:NET)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 117.25 and traded as low as GBX 109.55. Netcall shares last traded at GBX 109.55, with a volume of 157,652 shares changing hands.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on NET shares. Canaccord Genuity Group increased their price target on shares of Netcall from GBX 130 to GBX 150 and gave the stock a “buy” rating in a research note on Wednesday, October 8th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 155 target price on shares of Netcall in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 152.50.

Netcall Stock Down 0.8%

The company has a market capitalization of £183.20 million, a PE ratio of 45.49 and a beta of 0.23. The company has a debt-to-equity ratio of 1.19, a quick ratio of 0.88 and a current ratio of 1.22. The company’s 50-day moving average is GBX 115.97 and its 200 day moving average is GBX 117.25.

Netcall (LON:NET) last issued its earnings results on Wednesday, October 8th. The company reported GBX 3.75 earnings per share (EPS) for the quarter. Netcall had a net margin of 14.99% and a return on equity of 14.95%. As a group, analysts anticipate that Netcall plc will post 3.7029017 EPS for the current year.

About Netcall

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.